Search research articles
Contact Us
Filters
Showing results (271-280 of 288) with videos related to
Page
of 29
Sort By:
Blood
|
March 25, 2006
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial
Mats Brune, Sylvie Castaigne, John Catalano, et al.
Stem Cells (Dayton, Ohio)
|
May 9, 2014
Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?
Guido Moll, Jessica J Alm, Lindsay C Davies, et al.
Stem Cells (Dayton, Ohio)
|
April 24, 2012
Are therapeutic human mesenchymal stromal cells compatible with human blood?
Guido Moll, Ida Rasmusson-Duprez, Lena von Bahr, et al.
Journal of Innate Immunity
|
March 1, 2023
Combined Heterozygous Genetic Variations in Complement C2 and C8B: An Explanation for Multidimensional Immune Imbalance?
Marco Mannes, Rebecca Halbgebauer, Lisa Wohlgemuth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2
Annelie Liljegren, Gail Barker, Faye Elliott, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 12, 2017
Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects
Stephanie Denk, Miriam D Neher, David A C Messerer, et al.
Journal of Clinical Medicine
|
June 24, 2022
Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients
Rickard Lagedal, Oskar Eriksson, Anna Sörman, et al.
Blood Advances
|
June 11, 2026
In vivo evidence of effective complement modulation by TriFu in comparison to C5 inhibition and complement depletion
Susa Savukoski, Alina Maria Dettner, Anke Schultze, et al.
Journal of Autoimmunity
|
January 14, 2024
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile
Linnea Lindelöf, Solbritt Rantapää-Dahlqvist, Christian Lundtoft, et al.
Shock (Augusta, Ga.)
|
February 21, 2018
Protective Effects of the Complement Inhibitor Compstatin CP40 in Hemorrhagic Shock
Martijn van Griensven, Daniel Ricklin, Stephanie Denk, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 288) with videos related to
Sort By:
Page
of 29
Blood
|
March 25, 2006
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial
Mats Brune, Sylvie Castaigne, John Catalano, et al.
Stem Cells (Dayton, Ohio)
|
May 9, 2014
Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?
Guido Moll, Jessica J Alm, Lindsay C Davies, et al.
Stem Cells (Dayton, Ohio)
|
April 24, 2012
Are therapeutic human mesenchymal stromal cells compatible with human blood?
Guido Moll, Ida Rasmusson-Duprez, Lena von Bahr, et al.
Journal of Innate Immunity
|
March 1, 2023
Combined Heterozygous Genetic Variations in Complement C2 and C8B: An Explanation for Multidimensional Immune Imbalance?
Marco Mannes, Rebecca Halbgebauer, Lisa Wohlgemuth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2
Annelie Liljegren, Gail Barker, Faye Elliott, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 12, 2017
Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects
Stephanie Denk, Miriam D Neher, David A C Messerer, et al.
Journal of Clinical Medicine
|
June 24, 2022
Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients
Rickard Lagedal, Oskar Eriksson, Anna Sörman, et al.
Blood Advances
|
June 11, 2026
In vivo evidence of effective complement modulation by TriFu in comparison to C5 inhibition and complement depletion
Susa Savukoski, Alina Maria Dettner, Anke Schultze, et al.
Journal of Autoimmunity
|
January 14, 2024
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile
Linnea Lindelöf, Solbritt Rantapää-Dahlqvist, Christian Lundtoft, et al.
Shock (Augusta, Ga.)
|
February 21, 2018
Protective Effects of the Complement Inhibitor Compstatin CP40 in Hemorrhagic Shock
Martijn van Griensven, Daniel Ricklin, Stephanie Denk, et al.
Page
of 29